Table 3

Assessment, treatment and monitoring

	Pooled estimates			Hospital-specific estimates
Indicator	n	%	Cluster adjusted 95% CI	Median %*	Range %†
1. NAR used (n=1249)	711	57	36 to 78	75	0–100
2. Symptoms and signs
Symptom score (maximum 3)‡	0	0–3§	–	0	0–3
Sign score (maximum 8)¶	6	4–7§	–	5.8	0–8
3. Maternal HIV status
Status documented	674	54	42 to 66	64	0–93
Positive	83/674	12	8 to 20	9.1	0–56
ARV for PMTCT prescribed for baby	54/82	66	47 to 81	–	–
4. Antibiotic prescription
Benzylpenicillin dosage (n=778)
Appropriate	649	83	66 to 93	93	0–100
Overdose	90	12	3.4 to 33	4.2	0–100**
Gentamicin dosage (n=761)
Appropriate	473	62	51 to 73	67	7.7–91
Overdose	141	19	13 to 25	20	1.9–67
5. Supportive care
Vitamin K prescribed (n=1213)	843	70	57 to 80	73	10–100
Appropriate dose of intravenous fluids (n=473)††	290	61	52 to 71	57	0–90
Appropriate amount of feeds (n=109)††	55	51	26 to 75	14	0–100
6. Medical review and monitoring
Reviewed >24 h after admission (n=922)	20	2.2	1 to 4.8	0.8	0–21
Vital signs charted (n=1248)	970	78	68 to 87	85	8.3–100
Weight charted (n=1249)	510	41	25 to 56	39	0–100
Fluids monitored (n=559)‡‡	193	35	19 to 55	19	0–100

*Median of individual hospital median scores.
†Range of individual hospital median scores.
‡Difficulty feeding, convulsions and fits.
§IQR.
¶Temperature, bulging fontanelle, suck reflex/ability to feed, muscle tone, respiratory rate, severe indrawing, grunting and cyanosis.
**In the facility with 100% overdose, all penicillin doses were double the recommended.
††Treatment sheet with either intravenous fluids or supplementary feeds only for the first 24 h of life.
‡‡Five hundred and fifty-nine neonates had a fluid prescription on any day of life (473 of these on the first day).
ARV, antiretroviral; NAR, newborn admission record; PMTCT, preventing mother-to-child transmission.